TKG Advisors »

Vertex Pharmaceuticals Incorporated shares owned by TKG Advisors

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by TKG Advisors from 13F filings

Historical chart of TKG Advisors investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by TKG Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by TKG Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $317k 759 418.01
2023-12-31 $315k 773 406.89
2023-09-30 $315k 907 347.74
2023-06-30 $317k 902 351.91
2023-03-31 $426k 1.4k 315.07
2022-12-31 $390k 1.4k 288.78

More positions owned by TKG Advisors

Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Capital Group Intl Focus Eqt Shs Creation Uni (CGXU)
Ishares Msci Eurzone Etf (EZU)
Alphabet Cap Stk Cl C (GOOG)
NVIDIA Corporation (NVDA)
Spdr Ser Tr Portfoli S&p1500 (SPTM)
First Tr Exch Traded Fd Iii Instl Pfd Secs (FPEI)
Lam Research Corporation (LRCX)
Servicenow (NOW)
salesforce (CRM)
Ishares Tr Core S&p Scp Etf (IJR)

View all positions for TKG Advisors

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated